Clinical Trial Update: C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating completion of Phase 2 and Phase 3 studies of C1-Esteraseremmer-N for hereditary and acquired angioedema, sponsored by Prothya B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Angioedema
• Hereditary Angioedema

Drugs mentioned

• C1-Esteraseremmer-N

Snippet

Sponsor: Prothya Biosolutions | Conditions: Angioedema | Phase 2, Phase 3 | Status: COMPLETED